You are here

  • Home
  • Online First
  • Improving response to progestin treatment of low-grade endometrial cancer

Article info

Article menu

This article has a correction. Please see:

other Versions

Download PDFPDF
Review
Improving response to progestin treatment of low-grade endometrial cancer

Authors

  • Eva Baxter Queensland Centre for Gynaecological Cancer Research, The University of Queensland, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Donal J Brennan Department of Gynaecological Oncology, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, IrelandSystems Biology Ireland, University College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Jessica N McAlpine Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, The University of British Columbia, Vancouver, British Columbia, CanadaBC Cancer Agency, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Jennifer J Mueller Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USADepartment of Obstetrics & Gynecology, Weill Cornell Medical College, New York, New York, USA PubMed articlesGoogle scholar articles
  • Frédéric Amant Department of Oncology, KU Leuven, Leuven, Flanders, BelgiumCentre for Gynaecologic Oncology Amsterdam, Antoni van Leeuwenhoek Netherlands Cancer Institute and Amsterdam University Medical Centres, Amsterdam, Noord-Holland, The Netherlands PubMed articlesGoogle scholar articles
  • Mignon D J M van Gent Centre for Gynaecologic Oncology Amsterdam, Antoni van Leeuwenhoek Netherlands Cancer Institute and Amsterdam University Medical Centres, Amsterdam, Noord-Holland, The Netherlands PubMed articlesGoogle scholar articles
  • David G Huntsman BC Cancer Agency, Vancouver, British Columbia, CanadaDepartments of Pathology and Laboratory Medicine and Gynecology and Obstetrics, The University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Robert L Coleman Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Shannon N Westin Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Melinda S Yates Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Camilla Krakstad Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Vestland, NorwayDepartment of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Vestland, Norway PubMed articlesGoogle scholar articles
  • Michael A Quinn Royal Women's Hospital, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Monika Janda Centre for Health Services Research, The University of Queensland, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Andreas Obermair Queensland Centre for Gynaecological Cancer Research, The University of Queensland, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Eva Baxter, Queensland Centre for Gynaecological Cancer Research, Centre for Clinical Research, The University of Queensland, Brisbane, QLD 4029, Australia; e.baxter{at}uq.edu.au
View Full Text

Citation

Baxter E, Brennan DJ, McAlpine JN, et al
Improving response to progestin treatment of low-grade endometrial cancer
International Journal of Gynecologic Cancer Published Online First: 06 May 2020. doi: 10.1136/ijgc-2020-001309

Publication history

  • Received February 16, 2020
  • Revision received April 11, 2020
  • Accepted April 20, 2020
  • First published May 6, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.